SOLIGENIX, INC. Cash and Cash Equivalents
SOLIGENIX, INC. (SNGX) had Cash and Cash Equivalents of $22.88 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2022-05-13
- 2022-03-31: Cash and Cash Equivalents, at Carrying Value $22.88M.
- 2021-12-31: Cash and Cash Equivalents, at Carrying Value $26.04M.
- 2021-09-30: Cash and Cash Equivalents, at Carrying Value $28.87M.
- 2021-06-30: Cash and Cash Equivalents, at Carrying Value $28.98M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2022-03-31 | $22.88M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $26.04M 10-Q · filed 2022-05-13 |
| 2021-09-30 | $28.87M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $28.98M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $30.54M 10-Q · filed 2021-05-18 |
| 2020-12-31 | $18.68M 10-K · filed 2022-03-29 |
| 2020-09-30 | $11.34M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $11.17M 10-Q · filed 2021-08-13 |
| 2020-03-31 | $7.20M 10-Q · filed 2021-05-18 |
| 2019-12-31 | $5.42M 10-Q · filed 2021-11-12 |
| 2019-09-30 | $6.55M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $6.99M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $7.20M 10-Q · filed 2020-05-15 |
| 2018-12-31 | $8.98M 10-K · filed 2021-03-30 |
| 2018-09-30 | $11.72M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $4.24M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $6.37M 10-Q · filed 2019-05-14 |
| 2017-12-31 | $7.81M 10-K · filed 2020-03-30 |
| 2017-09-30 | $5.00M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $5.81M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $7.14M 10-Q · filed 2018-05-11 |
| 2016-12-31 | $8.77M 10-K · filed 2019-03-26 |
| 2016-09-30 | $5.66M 10-Q · filed 2017-11-06 |
| 2016-06-30 | $3.18M 10-Q · filed 2017-08-11 |
| 2016-03-31 | $4.26M 10-Q · filed 2017-05-11 |
| 2015-12-31 | $4.92M 10-K · filed 2018-03-15 |
| 2015-09-30 | $4.03M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $4.04M 10-Q · filed 2016-08-11 |
| 2015-03-31 | $5.01M 10-Q · filed 2016-05-12 |
| 2014-12-31 | $5.53M 10-K · filed 2017-03-27 |
| 2014-09-30 | $4.21M 10-Q · filed 2015-11-12 |
| 2014-06-30 | $5.04M 10-Q · filed 2015-08-12 |
| 2014-03-31 | $5.61M 10-Q · filed 2015-05-14 |
| 2013-12-31 | $5.86M 10-K · filed 2016-03-24 |
| 2013-09-30 | $6.58M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $8.13M 10-Q · filed 2014-08-11 |
| 2013-03-31 | $2.61M 10-Q · filed 2014-05-12 |
| 2012-12-31 | $3.36M 10-K · filed 2015-03-25 |
| 2012-09-30 | $3.70M 10-Q · filed 2013-11-12 |
| 2012-06-30 | $4.43M 10-Q · filed 2013-08-12 |
| 2012-03-31 | $5.32M 10-Q · filed 2013-05-03 |
| 2011-12-31 | $6.00M 10-K · filed 2014-03-26 |
| 2011-09-30 | $7.22M 10-Q · filed 2012-11-14 |
| 2011-06-30 | $4.16M 10-Q · filed 2012-08-10 |
| 2011-03-31 | $5.95M 10-Q · filed 2012-05-14 |
| 2010-12-31 | $7.45M 10-K · filed 2013-02-26 |
| 2010-09-30 | $9.03M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $10.81M 10-Q · filed 2011-08-12 |
| 2009-12-31 | $7.69M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |